Education Alert
Communicating to Enhance Care Through Data and Patient Experience: ER-Positive/HER2-Negative Metastatic Breast Cancer Edition
0.50 CME / CE / ABIM MOC
Did you know that benefits of transitioning from fulvestrant to oral SERDs are fewer clinic visits and more patient independence?